跳至主要内容
临床试验/NCT02453841
NCT02453841已完成不适用

Prospective Hemodynamic and Pharmacokinetic Analysis of Oxymetazoline Absorption During Functional Endoscopic or Turbinate Reduction Surgery or Adenoidectomy

Richard Cartabuke1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2015年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
Blood Pressure Following Oxymetazoline Administration

研究概览

简要总结

This proposed study will assess the hemodynamic effects and measure the systemic absorption of topically applied oxymetazoline in patients undergoing functional endoscopic sinus surgery, turbinate surgery, or adenoidectomy. These patients will be receiving oxymetazoline as standard of care during the surgery.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
2 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Patients that are scheduled for:
  • Functional endoscopic sinus surgery
  • Turbinate reduction (with or without tonsillectomy and/or adenoidectomy)
  • Adenoidectomy

排除标准

  • Been treated with oral decongestants or antihistamines within 24 hours of surgery
  • Are taking anticoagulants
  • Have a history of nasal trauma
  • Have a history of epistaxis
  • Have a history of hypertension or cardiac disease
  • Allergy to oxymetazoline

研究组 & 干预措施

FESS

Active Comparator

Patients undergoing functional endoscopic sinus surgery and receiving oxymetazoline as part of their surgery.

干预措施: Oxymetazoline (Drug)

Turbinates

Active Comparator

Patients undergoing turbinate reduction surgery and receiving oxymetazoline as part of their surgery.

干预措施: Oxymetazoline (Drug)

Adenoidectomy

Active Comparator

Patients undergoing an adenoidectomy and receiving oxymetazoline as part of their surgery.

干预措施: Oxymetazoline (Drug)

结局指标

主要结局

Blood Pressure Following Oxymetazoline Administration

时间窗: 5 - 150 mins. after administration

Blood pressure was recorded at 5 minute intervals until discharge from the post-anesthesia care unit (PACU) or the final blood draw (150 mins. after administration), whichever came first.

Heart Rate Following Oxymetazoline Administration.

时间窗: 5 - 150 mins. after administration

Heart rate was recorded at 5 minute intervals until discharge from the post-anesthesia care unit (PACU) or the final blood draw (150 mins. after administration), whichever came first.

次要结局

  • Ease of Hemostasis(intraoperative)
  • Amount of Bleeding(intraoperative)

研究者

发起方
Richard Cartabuke
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Richard Cartabuke

Co-Director of Outpatient Anesthesia Services

Nationwide Children's Hospital

研究点 (1)

Loading locations...

相似试验